Venture capital
AlgoTx
AlgoTx is developing a treatment for chemotherapy-induced neuropathic pain.
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2023
Investment team : Healthcare
THERAPIXEL
Artificial Intelligence (AI) tool to detect breast cancer breast cancer.
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Sud Provence-Alpes-Côte d’Azur
Investment date : 2022
Investment team : Healthcare
Domain Therapeutics
Domain Therapeutics is a biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Grand Est
Investment date : 2022
Investment team : Healthcare
CAIRDAC
French start-up develops a probeless double-chamber pacemaker with unrivalled longevity
Sector : Healthcare / Well-being
Activity : Venture capital
Investment date : 2022
Investment team : Healthcare
Stroma Care
Monoclonal antibodies (mAb) in oncology
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2022
Investment team : Healthcare
Keenturtle
Hospital prescription assistance software
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2021
Investment team : Healthcare
PathoQuest
Sequencing (NGS) for contaminant detection
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2021
Investment team : Healthcare
Mablink
Next-generation EDA development platform
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2021
Investment team : Healthcare
Germitec
UV disinfection of ultrasound probes
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2021
Investment team : Healthcare
InnoSkel
A newly launched platform biotechnology company pioneering gene therapies for rare skeletal diseases
Sector : Healthcare / Well-being
Activity : Venture capital
Investment date : 2020
Investment team : Healthcare
ABOLERIS PHARMA
Pre-clinical stage biotech company specialized in the development of innovative immuno-modulators for the treatment of transplant
rejection, graft-versus-host-disease and auto-immune diseases
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2020
Investment team : Healthcare
Dessintey
Established in 2017, Dessintey develops and sells IVS3, an innovative medical device to assist motor rehabilitation after stroke and treat chronic pain (complex regional pain syndrome – CRPS/algodystrophy) and pain resulting from amputation.
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2019
Investment team : Healthcare
Antabio
A specialist developer of treatments to counter antibiotic-resistant infections
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Occitanie
Investment date : 2018
Investment team : Healthcare
Carthera
Breakthrough innovation: a medical device dissociating the blood-brain barrier by ultrasound emission
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2018
Investment team : Healthcare
BRAINEVER
Fighting Rett syndrome
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2015
Investment team : Lyon
Coave Therapeutics
Thérapie génique pour les maladies ultra orphelines de l’œil
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Île-de-France
Investment date : 2015
Investment team : Healthcare
AMOLYT PHARMA
Advancing peptides for the treatment of rare endocrine and metabolic disorders
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2014
Investment team : Healthcare
Eye Tech Care
Non-invasive therapeutic devices to treat diseases such as glaucoma
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2014
Investment team : Lyon
OREGA BIOTECH
Developing immunotherapies for cancer
Sector : Healthcare / Well-being
Activity : Venture capital
Location : Auvergne-Rhône-Alpes
Investment date : 2014
Investment team : Lyon
Chargement...
